The novel approach of the medication represents a major development in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide affects two pathways – GLP-1 and the GIP hormone – resulting in https://tirzepatide-peptide720303.blogerus.com/64101185/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment